These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33393765)

  • 21. Rhabdomyolysis Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).
    Teng C; Baus C; Wilson JP; Frei CR
    Int J Med Sci; 2019; 16(11):1504-1509. PubMed ID: 31673242
    [No Abstract]   [Full Text] [Related]  

  • 22. Characteristics of drug-associated rhabdomyolysis: analysis of 8,610 cases reported to the U.S. Food and Drug Administration.
    Oshima Y
    Intern Med; 2011; 50(8):845-53. PubMed ID: 21498932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-atlas-based auto-segmentation for prostatic urethra using novel prediction of deformable image registration accuracy.
    Takagi H; Kadoya N; Kajikawa T; Tanaka S; Takayama Y; Chiba T; Ito K; Dobashi S; Takeda K; Jingu K
    Med Phys; 2020 Jul; 47(7):3023-3031. PubMed ID: 32201958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential for conflict of interest in the evaluation of suspected adverse drug reactions: use of cerivastatin and risk of rhabdomyolysis.
    Psaty BM; Furberg CD; Ray WA; Weiss NS
    JAMA; 2004 Dec; 292(21):2622-31. PubMed ID: 15572720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In silico prediction of rhabdomyolysis of compounds by self-organizing map and support vector machine.
    Hu X; Yan A
    Toxicol In Vitro; 2011 Dec; 25(8):2017-24. PubMed ID: 21856410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How serious is the bronchospasm induced by rapacuronium?
    Naguib M
    Anesthesiology; 2001 May; 94(5):924-5. PubMed ID: 11388547
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug-induced rhabdomyolysis.
    Coco TJ; Klasner AE
    Curr Opin Pediatr; 2004 Apr; 16(2):206-10. PubMed ID: 15021204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute myopathy complicating prolonged curarization and corticoid therapy for status asthmaticus].
    Vasquez JL; Roux L; Salame M; Maindivide J
    Presse Med; 1992 Sep; 21(30):1433. PubMed ID: 1360662
    [No Abstract]   [Full Text] [Related]  

  • 30. Prediction of pharmacokinetic drug-drug interactions causing atorvastatin-induced rhabdomyolysis using physiologically based pharmacokinetic modelling.
    Li S; Yu Y; Jin Z; Dai Y; Lin H; Jiao Z; Ma G; Cai W; Han B; Xiang X
    Biomed Pharmacother; 2019 Nov; 119():109416. PubMed ID: 31518878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Machine learning algorithms to predict early pregnancy loss after in vitro fertilization-embryo transfer with fetal heart rate as a strong predictor.
    Liu L; Jiao Y; Li X; Ouyang Y; Shi D
    Comput Methods Programs Biomed; 2020 Nov; 196():105624. PubMed ID: 32623348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction and analysis of a human hepatotoxicity database suitable for QSAR modeling using post-market safety data.
    Zhu X; Kruhlak NL
    Toxicology; 2014 Jul; 321():62-72. PubMed ID: 24721472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapacuronium: premarket drug evaluation can be very effective for the identification of drug risks.
    Lim R
    Anesth Analg; 2003 Feb; 96(2):631-2. PubMed ID: 12538231
    [No Abstract]   [Full Text] [Related]  

  • 34. Prediction of drug-related cardiac adverse effects in humans--B: use of QSAR programs for early detection of drug-induced cardiac toxicities.
    Frid AA; Matthews EJ
    Regul Toxicol Pharmacol; 2010 Apr; 56(3):276-89. PubMed ID: 19941924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and pharmacodynamics of rapacuronium bromide.
    Wight WJ; Wright PM
    Clin Pharmacokinet; 2002; 41(13):1059-76. PubMed ID: 12403643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precipitation of thiopental by rapacuronium.
    Schmidt U; Basta SR; Shank ES
    Anesthesiology; 2001 Jul; 95(1):273. PubMed ID: 11465575
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities.
    Matthews EJ; Ursem CJ; Kruhlak NL; Benz RD; Sabaté DA; Yang C; Klopman G; Contrera JF
    Regul Toxicol Pharmacol; 2009 Jun; 54(1):23-42. PubMed ID: 19422098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further comments on the withdrawal of rapacuronium.
    Sosis MB
    Anesth Analg; 2002 Oct; 95(4):1126-7. PubMed ID: 12351320
    [No Abstract]   [Full Text] [Related]  

  • 39. Progress in Predicting Ames Test Outcomes from Chemical Structures: An In-Depth Re-Evaluation of Models from the 1st and 2nd Ames/QSAR International Challenge Projects.
    Uesawa Y
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioactive Molecule Prediction Using Extreme Gradient Boosting.
    Babajide Mustapha I; Saeed F
    Molecules; 2016 Jul; 21(8):. PubMed ID: 27483216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.